Tracking CADL? Get live short interest, options flow, and signals on ORTEX.Sign up free →

Candel Therapeutics, Inc. (CADL) short interest & options flow

NASDAQ

Candel Therapeutics heads into October with short sellers firmly entrenched, an activist on the register, and analysts who have just turned notably more constructive, a combination that sets up a pointed disagreement about where this development-stage biotech goes from here. The short position is one of the more significant in small-cap biotech right now. Short interest has climbed…

$9.22-1.39% 1d+1.88% 1w-7.24% 1mClose: 11 Nov 2026

Short interest % of float: High; Live SI on ORTEX →
Cost to borrow: Rising; Live CTB on ORTEX →
Availability: Low and dropping; Live availability on ORTEX →

Market cap: $705M
Next earnings: 13 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Candel Therapeutics, Inc. (CADL) share price and short interest (% of free float), six months to November 11, 2026

CADL news and analysis

RSS

No long-form analysis yet for CADL. Pulse alerts and the live data picture are available on ORTEX.

Open CADL on ORTEX →

Want the live picture for CADL?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CADL — free to start on ORTEX.

We value your privacy

CADL news and analysis

Want the live picture for CADL?